Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study

OBJECTIVE: To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carcinoma (mRCC). METHODS: A total of 177 mRCC patients using sorafenib as first- (N = 116), second- (N = 43), and third-line (N = 18) therapies were enrolled from 11 Korean centers between 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Kim, Sohee, Nam, Byung-Ho, Lee, Sang Eun, Kim, Choung Soo, Seo, Ill Young, Kim, Tae Nam, Hong, Sung-Hoo, Kwon, Tae Gyun, Seo, Seong Il, Joo, Kwan Joong, Song, Kanghyon, Kwak, Cheol, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550402/
https://www.ncbi.nlm.nih.gov/pubmed/26308612
http://dx.doi.org/10.1371/journal.pone.0135165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550402/
https://www.ncbi.nlm.nih.gov/pubmed/26308612
http://dx.doi.org/10.1371/journal.pone.0135165

Ejemplares similares